CatalystFDA/Bio

FDA Accepts & Gives Priority Review to Intellia's BLA for HAE Drug

Priority review accelerates FDA decision, boosting Intellia's HAE drug approval odds.

What changed

Priority review accelerates FDA decision, boosting Intellia's HAE drug approval odds.

Why it matters

Priority review accelerates FDA decision, boosting Intellia's HAE drug approval odds. — impact context not separately stored; see What changed.

Sources

FDA Accepts &amp; Gives Priority Review to Intellia's BLA for HAE Drug